Clinical challenges posed by new biotechnology
نویسندگان
چکیده
منابع مشابه
New HDL Research Challenges posed by Dynamically
Dynamically re-programmable hardware (e.g. Field Programmable Gate Arrays or FPGAs) change many of our basic assumptions of what hardware is. Normal hardware design focuses on the development of a static circuit of xed size, topology and functionality. The static nature of the target design entity is re ected in the design of CAD tools, hardware description languages, net-list representations a...
متن کاملNew challenges and opportunities for industrial biotechnology
Industrial biotechnology has not developed as fast as expected due to some challenges including the emergences of alternative energy sources, especially shale gas, natural gas hydrate (or gas hydrate) and sand oil et al. The weaknesses of microbial or enzymatic processes compared with the chemical processing also make industrial biotech products less competitive with the chemical ones. However,...
متن کاملPublic health challenges posed by chemical mixtures.
Approximately 40 million people live within a 4-mile radius of waste sites that the Agency for Toxic Substances and Disease Registry (ATSDR) has assessed to date. Human populations living in the vicinity of such sites are often subjected to complex chemical exposures that may contribute to the total body burden of oxogenous chemicals. Apart from the contaminants found at waste sites, exposure m...
متن کاملTherapeutic challenges posed by bacterial bioterrorism threats.
The events of the autumn of 2001 in the United States made it clear that the spectre of the use of microorganisms to intentionally harm humans is a reality. The current strategy to control disease outbreaks caused by the intentional release of bacteria is to use antimicrobial agents, both therapeutically and prophylactically. However, multidrug-resistant strains of bacterial bioterrorism agents...
متن کاملEthical challenges posed by clinical trials in preterm labor: a case study
This paper explores the ethical implications of a randomized double-blind clinical trial aimed to determine effectiveness and safety of an oxytocin receptor antagonist versus a betamimetic in the treatment of preterm labor, presented to a teaching hospital affiliated with a private university in Santiago, Chile. Though this trial protocol fulfills one of the conditions under which pregnant wome...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 2003
ISSN: 0032-5473
DOI: 10.1136/pmj.79.928.65